http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20080026386-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb0d9a06f4c98fe19ed3db1ae100d48e |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
filingDate | 2006-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7bae799a1f353d377f5883b3bcc2e5f |
publicationDate | 2008-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20080026386-A |
titleOfInvention | Pharmaceutical composition for preventing and treating neurological diseases containing ginsenoside as active ingredient |
abstract | The present invention relates to a pharmaceutical composition for preventing and treating neurological diseases containing ginseng saponin (ginseng saponin) as an active ingredient, and more particularly, ginsenosides having a neuroprotective effect by inhibiting inducible excitotoxicity. The present invention relates to a pharmaceutical composition for preventing and treating cranial nerve disease, comprising Rg (ginsenoside Rg) as an active ingredient. The pharmaceutical composition of the present invention inhibits the death of hippocampal cells, inhibits DNA damage, enhances related enzyme activity, and regulates intracellular Ca 2+ concentration, thereby effectively preventing or treating various neurological diseases and the like without any human side effects. It can be widely used as a medicine. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101452309-B1 |
priorityDate | 2006-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 134.